AusBiotech CEO Lorraine Chiroiu says the change to the R&D Tax Incentive is a "hidden detail" in the bill that will impact "vulnerable enterprises" focused on developing new therapies, devices, vaccines and diagnostics. …
Latest Video
New Stories
-
There are 'reviews and there are reviews'
May 21, 2019 - - Latest News -
New 'unit' to support consumer input
May 21, 2019 - - Latest News -
AusBiotech marks International Clinical Trials Day
May 21, 2019 - - Latest News -
Merck's Leah Goodman says the 'long term' is now
May 20, 2019 - - PharmaDispatch Executive -
Celltrion announces global expansion plan
May 20, 2019 - - Latest News -
Who predicted this?
May 20, 2019 - - Latest News -
PharmaDispatch 2019: Election outcome an early focus
May 20, 2019 - - Latest News